Cargando…

Usefulness of C-reactive protein in monitoring the severe community-acquired pneumonia clinical course

BACKGROUND: The aim of the present study was to evaluate the C-reactive protein level, the body temperature and the white cell count in patients after prescription of antibiotics in order to describe the clinical resolution of severe community-acquired pneumonia. METHODS: A cohort of 53 consecutive...

Descripción completa

Detalles Bibliográficos
Autores principales:	Coelho, Luís, Póvoa, Pedro, Almeida, Eduardo, Fernandes, Antero, Mealha, Rui, Moreira, Pedro, Sabino, Henrique
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2007
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2206486/ https://www.ncbi.nlm.nih.gov/pubmed/17723153 http://dx.doi.org/10.1186/cc6105

Ejemplares similares

Early identification of intensive care unit-acquired infections with daily monitoring of C-reactive protein: a prospective observational study
por: Póvoa, Pedro, et al.
Publicado: (2006)

Severe community-acquired pneumonia: in search of the guiding star
por: Póvoa, Pedro, et al.
Publicado: (2023)

Patterns of c-reactive protein RATIO response in severe community-acquired pneumonia: a cohort study
por: Coelho, Luís M, et al.
Publicado: (2012)

Kinetics of C-Reactive Protein and Procalcitonin in the Early Identification of ICU-Acquired Infections in Critically Ill COVID-19 Patients
por: Cidade, José Pedro, et al.
Publicado: (2023)

Cardiovascular Events after Community-Acquired Pneumonia: A Global Perspective with Systematic Review and Meta-Analysis of Observational Studies
por: Tralhão, António, et al.
Publicado: (2020)

Corticosteroids in severe community-acquired pneumonia: the path we choose depends on where we want to get
por: Salluh, Jorge IF, et al.
Publicado: (2011)

The role of corticosteroids in severe community-acquired pneumonia: a systematic review
por: Salluh, Jorge IF, et al.
Publicado: (2008)

The role of corticosteroids in severe community-acquired pneumonia: a systematic review
por: Salluh, Jorge IF, et al.
Publicado: (2008)

C-reactive protein, an early marker of community-acquired sepsis resolution: a multi-center prospective observational study
por: Póvoa, Pedro, et al.
Publicado: (2011)

Management of severe community-acquired pneumonia in Brazil: a secondary analysis of an international survey
por: Rabello, Lígia, et al.
Publicado: (2015)

Should C-reactive protein concentration at ICU discharge be used as a prognostic marker?
por: Silvestre, Joana, et al.
Publicado: (2010)

Airway and Respiratory Devices in the Prevention of Ventilator-Associated Pneumonia
por: Coelho, Luis, et al.
Publicado: (2023)

Association of C-Reactive Protein and Outcome in Patients With Community-Acquired Pneumonia
por: Park, JK, et al.
Publicado: (2015)

CURB-65 and Long-Term Mortality of Community-Acquired Pneumonia: A Retrospective Study on Hospitalized Patients
por: Carlos, Pedro, et al.
Publicado: (2023)

P24 Auditing antibiotic course lengths for the management of community-acquired pneumonia and hospital-acquired pneumonia against current NICE guidance
por: Chua, Elaine, et al.
Publicado: (2023)

Community‐Acquired Pneumonia
Publicado: (2007)

COMMUNITY-ACQUIRED PNEUMONIA
por: Haas, Andrew R., et al.
Publicado: (2009)

Community-acquired pneumonia
por: File, Thomas M
Publicado: (2003)

Community-Acquired Pneumonia
por: Sialer, Salvador, et al.
Publicado: (2014)

Community Acquired Pneumonia
por: Wunderink, Richard G., et al.
Publicado: (2016)

Community-Acquired Pneumonia
por: Boza Costagliola, María Lina
Publicado: (2020)

Community Acquired Pneumonia
por: Wunderink, Richard G.
Publicado: (2019)

Community-Acquired Pneumonia
por: Rider, Ashley C., et al.
Publicado: (2018)

Community-acquired pneumonia
por: Niederman, Michael S.
Publicado: (2010)

Community-Acquired Pneumonia
por: Wunderink, Richard G.
Publicado: (2017)

Community-acquired pneumonia
por: Prina, Elena, et al.
Publicado: (2015)

Community Acquired Pneumonia
por: Finch, Roger
Publicado: (1998)

Effect of corticosteroids on the clinical course of community-acquired pneumonia: a randomized controlled trial
por: Fernández-Serrano, Silvia, et al.
Publicado: (2011)

Markov State Modelling of Disease Courses and Mortality Risks of Patients with Community-Acquired Pneumonia
por: Przybilla, Jens, et al.
Publicado: (2020)

C-reactive protein as an early marker of sepsis resolution: results from the Portuguese Community-acquired Sepsis Study (SACiUCI study)
por: Povoa, P, et al.
Publicado: (2011)

Efficacy and Safety of Nemonoxacin in Outpatients with Community-Acquired Pneumonia
por: Zhao, Bo, et al.
Publicado: (2020)

Incidence of Antibiotic Treatment Failure in Patients with Nursing Home-Acquired Pneumonia and Community Acquired Pneumonia
por: Lopes, Mariana, et al.
Publicado: (2021)

Prescription of antibiotics in community-acquired pneumonia in children: are we following the recommendations?
por: da Fonseca Lima, Eduardo Jorge, et al.
Publicado: (2016)

Community-Acquired Viral Pneumonia
por: Falsey, Ann R.
Publicado: (2007)

Community-acquired pneumonia in children
por: Davies, H Dele
Publicado: (2003)

Epidemiology of community acquired pneumonia
por: Manikam, Logan, et al.
Publicado: (2012)

Community-Acquired Pneumonia in Childhood
por: Popovsky, Erica Y., et al.
Publicado: (2022)

Severe community-acquired pneumonia
por: Morgan, AJ, et al.
Publicado: (2016)

Severe Community-Acquired Pneumonia
por: Khatib, Khalid, et al.
Publicado: (2019)

Issues in Community-Acquired Pneumonia
por: Fong, I. W.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_vgb2f0ci7i88quoslt4vi6v8s3